0001019056-18-000291.txt : 20180206 0001019056-18-000291.hdr.sgml : 20180206 20180206192332 ACCESSION NUMBER: 0001019056-18-000291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180203 FILED AS OF DATE: 20180206 DATE AS OF CHANGE: 20180206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stromatt Scott C CENTRAL INDEX KEY: 0001679975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 18578960 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 stromatt_4.xml OWNERSHIP DOCUMENT X0306 4 2018-02-03 0 0001671584 Aptevo Therapeutics Inc. APVO 0001679975 Stromatt Scott C 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 0 1 0 0 Chief Medical Officer and SVP Common Stock 2018-02-03 4 M 0 27381 A 174576 D Restricted Stock Unit 2018-02-03 4 M 0 27381 0 D Common Stock 27381 46430 D Each RSU converts into the Issuer's common stock on a one-for-one basis. On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. /s/ Benjamin J. Stein, attorney-in-fact 2018-02-06